Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Bühler, Silja; Jaeger, V K; Adler, S; Bannert, B; Brümmerhoff, C; Ciurea, A; Distler, O; Franz, J; Gabay, C; Hagenbuch, Nils; Herzog, C; Hasler, P; Kling, K; Kyburz, D; Müller, R; Nissen, M J; Siegrist, C A; Villiger, P M; Walker, U A; Hatz, C (2019). Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study. Rheumatology, 58(9):1585-1596.

Mach, F; Gabay, C; Buchs, N; Dudler, J; Gencer, B; Hasler, P; Matter, C; Michel, B A; von Kempis, J; Zufferey, P (2015). Consensus guidelines on the cardiovascular risk management in patients with rheumatoid arthritis. Cardiovascular Medicine, 4(18):127-133.

Kyburz, D; Gabay, C; Michel, B A; Finckh, A (2011). The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study. Rheumatology, 50(6):1106-1110.

Finckh, A; Ciurea, A; Brulhart, L; Möller, B; Walker, U A; Courvoisier, D; Kyburz, D; Dudler, J; Gabay, C (2010). Which subgroup of rheumatoid arthritis patients benefits from switching to rituximab versus alternative anti-TNF agents after previous failure to anti-TNF agent? Annals of the Rheumatic Diseases, 69(2):387-393.

Finckh, A; Dudler, J; Wermelinger, F; Ciurea, A; Kyburz, D; Gabay, C; Bas, S (2010). Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients. Joint, Bone, Spine, 77(4):313-318.

Finckh, A; Dehler, S; Gabay, C (2009). The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study. Annals of the Rheumatic Diseases, 68(1):33-39.

Du Pan, S M; Dehler, S; Ciurea, A; Ziswiler, H R; Gabay, C; Finckh, A (2009). Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis. Arthritis and Rheumatism, 61(5):560-568.

Finckh, A; Ciurea, A; Brulhart, L; Kyburz, D; Möller, B; Dehler, S; Revaz, S; Dudler, J; Gabay, C (2007). B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Arthritis and Rheumatism, 56(5):1417-1723.

Finckh, A; Dehler, S; Costenbader, K H; Gabay, C (2007). Cigarette smoking and radiographic progression in rheumatoid arthritis. Annals of the Rheumatic Diseases, 66(8):1066-1071.

This list was generated on Sat Aug 24 23:24:48 2019 CEST.